Limited and its subsidiaries (“the Company”) would like to clarify herewith the operating result for Quarter 2 Ended 30-June-2019 as follows:- Financial Position As at 30 June 2019 total assets of
cost to sale of biological assets. Financial Cost Financial cost in Quarter 2/2019 was Baht 8.5 Million decreased by Baht 1.3 Million or 13.1% from Q2/2018 mainly from bank loan repayment in 2018. Net
. Because of in the Company’ posted a net profit decreased. 4 Financial Status Total Assets As of June 30, 2019 the company and its subsidiaries’ total assets stood Baht 4,097.07 million, which was a Baht
-month and Six-month Periods Ended 30 June, 2019 Page 9 4. Analysis of statement of financial position 4.1 Analysis of assets As at June 30, 2019, the total assets were Baht 99,156.02 million, decreasing
the financial status as of March 31, 2018 are summarized as below: Assets As of March 31, 2018, the Company and its subsidiaries have a total asset by 703 MB which decreased from December 31, 2017 by
reasons: Current assets as amounting of 2,779.38 Million Baht (138.39 Million Baht increased) when compared to December 31, 2017 as amount of 2,640.99 Million Baht by having more cash and cash equivalents
. The transaction size is exceeding to 0.03 percent, but not exceeding to 3.00 percent of the Company’s Net Tangible Assets (NTA). Therefore, it is deemed as a connected transaction of which needed to be
Assets (NTA). Therefore, it is deemed as a connected transaction of which needed to be approved the entering into a transaction by the Board of Directors and required to disclosed to the SET in compliance
financial status as of December 31, 2017 are summarized as below: Assets As of June 30, 2018, the Company and its subsidiaries had a total asset by 698.5 MB which decreased from December 31, 2017 at 5.7 MB
Status Total Assets As of June 30, 2018 the company and its subsidiaries’ total assets stood Baht 4,565.25 million, which was a Baht 199.97 million or 4.20 percent decreased from as of December 31, 2017